Cowen And Company, LLC Atreca, Inc. Put Options Transaction History

Cowen And Company, LLC

  • $3.91 Billion
  • Q2 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$4.91 - $9.07 $158,102 - $292,054
-32,200 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$7.82 - $13.8 $251,804 - $444,360
32,200 New
32,200 $6,000

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email